Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Enveric Biosciences Inc (NQ: ENVB )

4.110 -0.520 (-11.23%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 7, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 167,804
Open 4.540
Bid (Size) 4.160 (1)
Ask (Size) 4.290 (2)
Prev. Close 4.630
Today's Range 4.050 - 4.600
52wk Range 1.300 - 18.50
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Enveric Biosciences Announces Two Poster Presentations at the Canadian Chemistry Conference and Exhibition (CSC 2023)
From Enveric Biosciences, Inc.
Via Business Wire
Enveric Stock Trading Higher On Notice Of Allowance For Patent Application For Its Carboxylated Psilocybin Derivatives
Enveric Biosciences, Inc. (NASDAQ: ENVB) has received a notice of allowance from the United States Patent and Trademark Office (USPTO) for a patent application pertaining to its EVM301 series of... 
Via Benzinga

Performance

YTD
+78.70%
+78.70%
1 Month
+99.51%
+99.51%
3 Month
+107.58%
+107.58%
6 Month
+56.27%
+56.27%
1 Year
-62.22%
-62.22%

More News

Read More
Enveric Biosciences Receives Notice of Allowance from USPTO for EVM301 Series of Drug Candidates
From Enveric Biosciences, Inc.
Via Business Wire
Enveric Biosciences Inc. (NASDAQ: ENVB) Leading the Way in Wednesday Trading Based on Percentage Gain
Via Investor Brand Network
Psyched: LSD Microdosing For Depression, DMT For Anxiety, MDMA Octopuses And More
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Enveric Biosciences Announces Poster Presentation at Canadian Neuroscience Meeting 2023
From Enveric Biosciences, Inc.
Via Business Wire
Enveric Biosciences Rallies 300% As It Receives US Patents For Psychedelic Compounds
Via Talk Markets
Why Nvidia Shares Are Trading Higher By Over 5%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Why Dollar Tree Shares Are Trading Lower By 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Why Nutanix Shares Are Trading Higher By 16%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Crude Oil Rises 2%; Kohl's Reports Surprise Q1 Profit
Via Benzinga
Why Are Enveric Biosciences Shares Climbing?
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Nasdaq Down 1%; US Crude Oil Inventories Decline Last Week
Via Benzinga
Dow Falls Over 100 Points; Analog Devices Posts Upbeat Q2 Earnings
Via Benzinga
Why America's Car-Mart Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Enveric Stock Soars On Reception Of Notice Of Allowance For Patent Application For Its Psilocin Prodrug Designs
Via Benzinga
Enveric Biosciences Receives Notice of Allowance From USPTO for C4-Carboxylic Acid-Substituted Tryptamine Derivatives for Next Generation Psilocin Prodrug
From Enveric Biosciences, Inc.
Via Business Wire
Psyched: New Psilocybin Forms, LSD Anxiety Study, UK's Parliamentary Debate And More
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Why ZIM Integrated Shipping Services Shares Are Trading Lower By 14%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.